Northland Capital Markets Downgrades Adamas Pharmaceuticals (ADMS) to Market Perform
Tweet Send to a Friend
Northland Capital Markets analyst Carl Byrnes downgraded Adamas Pharmaceuticals (NASDAQ: ADMS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
